The American Journal Of Medicine Now Recommends HCQ For COVID19

The currently completed retrospective studies and randomized trials have generally shown these findings: 1) when started late in the hospital course and for short durations of time, antimalarials appear to be ineffective, 2) when started earlier in the hospital course, for progressively longer durations and in outpatients, antimalarials may reduce the progression of disease, prevent hospitalization, and are associated with reduced mortality.

10 thoughts on “The American Journal Of Medicine Now Recommends HCQ For COVID19

  1. Hi Dr. Stuart, Access to “The American Journal Of Medicine Now Recommends HCQ For COVID19” by the Blogging Hounds has been blocked for reposting. Facebook are not letting people who have alternative therapies or cures of Covid 19 where they might put big Pharma profits in jeopardy. It was bound to happen, there will be more censuring to follow, you can be sure of it.

    Liked by 1 person

Leave a reply to stuartbramhall Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.